Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-2002 | 10-2001 | 07-2001 | 04-2001 | 01-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 168,794 | 120,158 | 135,188 | 231,575 | 260,669 |
| Marketable Securities | 172,145 | 229,335 | 220,086 | 132,154 | 109,235 |
| Receivables | 700 | N/A | N/A | N/A | N/A |
| Other current assets | 935 | 7,167 | 6,980 | 3,900 | 5,532 |
| TOTAL | $343,661 | $357,022 | $362,747 | $368,139 | $375,970 |
| Non-Current Assets | |||||
| PPE Net | 13,459 | 13,388 | 13,731 | 13,487 | 12,627 |
| Intangibles | 20,165 | 20,230 | 20,270 | 21,116 | 21,940 |
| Other Non-Current Assets | 6,230 | 3,370 | 3,511 | 3,687 | 3,978 |
| TOTAL | $39,854 | $36,988 | $37,512 | $38,290 | $38,545 |
| Total Assets | $383,515 | $394,010 | $400,259 | $406,429 | $414,515 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,597 | 1,213 | 1,722 | 1,630 | 2,826 |
| Accrued Expenses | 5,374 | 4,273 | 4,917 | 3,789 | 4,576 |
| TOTAL | $9,581 | $6,913 | $7,991 | $6,957 | $8,381 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,920 | 3,920 | 3,920 | 3,920 | 3,920 |
| Deferred Revenues | 610 | 1,427 | 1,352 | 1,446 | 788 |
| Other Non-Current Liabilities | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 |
| TOTAL | $131,566 | $131,713 | $131,860 | $132,008 | $123,920 |
| Total Liabilities | $141,147 | $138,626 | $139,851 | $138,965 | $132,301 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,513 | 72,471 | N/A | 72,390 | 72,299 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -142,856 | -132,046 | -124,257 | -116,721 | -101,435 |
| Other shareholders' equity | 795 | 3,233 | 572 | 359 | 43 |
| TOTAL | $242,368 | $255,384 | $260,408 | $267,464 | $282,214 |
| Total Liabilities And Equity | $383,515 | $394,010 | $400,259 | $406,429 | $414,515 |